期刊文献+

PI3K/AKT/mTOR信号通路参与自身免疫性疾病发病的研究进展 被引量:2

Research progress of PI3K/AKT/mTOR signaling pathway in pathogenesis of autoimmune diseases
下载PDF
导出
摘要 自身免疫性疾病(autoimmune disease,AD)是机体因自身抗原免疫耐受障碍而对自身抗原产生免疫反应,从而引起机体组织损伤的一类疾病。近年研究发现,磷脂酰肌醇-3-激酶/蛋白激酶B/雷帕霉素靶蛋白(phosphatidylin ositol 3-kinase/protein kinase B/mechanistic target of rapamycin kinase,PI3K/AKT/mTOR)信号通路与AD发病密切相关,其主要参与免疫细胞增殖分化、炎性细胞因子分泌、自噬及氧化应激等过程。本文重点概述PI3K/AKT/mTOR信号通路参与AD发病机理的研究进展。 Autoimmune diseases(ADs)are a kind of diseases caused by the disorder of immune tolerance and the immune response to autoimmune antigens.Recent studies have found that there are close relationship between the phosphatidylinositol-3-kinase/protein kinase B/target of rapamycin(PI3K/AKT/mTOR)signaling pathway and AD,mainly involved in immune cell proliferation and differentiation,inflammatory cytokine secretion,autophagy levels,and abnormal oxidative stress.This review focuses on the research progress of PI3K/AKT/mTOR signaling pathway in the pathogenesis of AD.
作者 何呈燕 马蕾 薛海波 He Chengyan;Ma Lei;Xue Haibo(Department of Endocrinology,Binzhou Medical University Hospital,Binzhou 256603,China;Department of Dermatology,Binzhou Medical University Hospital,Binzhou 256603,China)
出处 《国际医药卫生导报》 2022年第15期2089-2093,共5页 International Medicine and Health Guidance News
基金 国家自然科学基金(81803145) 山东省研究生教育创新计划项目(20038612) 滨州医学院附属医院科研创新团队项目(202030) 滨州医学院附属医院后备领军人才项目(JC2019-03)。
关键词 PI3K AKT MTOR 自身免疫性疾病 PI3K AKT mTOR Autoimmune diseases
  • 相关文献

参考文献4

二级参考文献46

  • 1Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulkl. Nat Cell Biol 2011; 13:132-141.
  • 2Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012; 149:274-293.
  • 3Ben-Sahra I, Howell JJ, Asara JM, Manning BD. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science 2013; 339:1323-1328.
  • 4Robitaille AM, Christen S, Shimobayashi M, et al. Quantita- tive phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. Science 2013; 339:1320-1323.
  • 5Jacinto E, Loewith R, Schmidt A, et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004; 6: 1122-1128.
  • 6Sarbassov DD, Oucrtin DA, Ali SM, Sabatini DM. Phosphor- ylation and regulation of Akt/PKB by thc dctor-mTOR cam- plex. Science 2005; 307: 1098-1101.
  • 7Sarbasqov DD, Ali SM, Sengupta S, et al. Prolonged rapamy- cin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 2006; 22:150-168.
  • 8(iarcia-Martincz J M, Alessi DR. roTOR complex 2 (mTORC2) controla hydrophobic motif phosphorylation and activation of serum- and glueocorticoid-indueed protein kinase 1 (SGK1). Riochem J 2008; 416:375-385.
  • 9Guertin DA, ,qtcvcns DM, Thorcen CC, et al. Ablation in mice of the mTORC componcnts raptor, rictor, or mLST8 rcveals that mTORC2 is required for sip, haling to Akt-FOXO and PKCalpha, but not S6K 1. Dev Cell 2006; 11:859-871.
  • 10Dibble CC, Asara JM, Manning BD. Characterization of Ric- tor phosphorylation sites reveals direct regulation of roTOR complex 2 by S6K 1. Mol Cell Biol 2009; 29:5657-5670.

共引文献23

同被引文献32

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部